MSR21 Cost-Effectiveness Analysis of Treatments for Nonsense Mutation Duchenne Muscular Dystrophy: Expert Validation of Model Face Validity
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.1228
https://www.valueinhealthjournal.com/article/S1098-3015(22)01429-2/fulltext
Section Title :
Section Order :
11097
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01429-2&doi=10.1016/j.jval.2022.04.1228